Loading clinical trials...
Loading clinical trials...
Performance evaluation of a novel, semi-automated device and method for needle core biopsy download compared to standard methods in terms of: 1. Biopsy core length obtained (i.e. collecting all tissue fragments) 2. Biopsy core yield (i.e. percent of tissue loss during the pathologic processing) 3. Pathologist interpretability 4. Processing time 5. Prostate cancer detection.
Age
18 - No limit years
Sex
MALE
Healthy Volunteers
No
Haemek madical center
Afula, Israel
Start Date
April 29, 2013
Primary Completion Date
April 5, 2017
Completion Date
April 24, 2017
Last Updated
April 19, 2019
436
ACTUAL participants
NaviGo Bx™
DEVICE
biopsy sponge pad
PROCEDURE
Lead Sponsor
UC Care, Ltd.
NCT04550494
NCT06842498
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05691465